Mycoplasma Pneumoniae Antibody (IgG)

Sample type: Serum
Optimal result: 0 – 0.9 Units

The detection of elevated Mycoplasma Pneumoniae Antibody (IgG) levels in a person's serum is significant as it typically indicates exposure to Mycoplasma pneumoniae, a common cause of atypical pneumonia and other respiratory illnesses.

Elevated IgG levels are particularly indicative of a past infection or an immune response that has been ongoing for some time. Unlike IgM antibodies, which appear early in an infection and suggest acute or recent exposure, IgG antibodies develop later and can persist long-term in the patient's system.

Therefore, a high IgG titer can imply either a recent past infection or a reactivation of a latent infection, especially in cases where a patient presents with symptoms consistent with Mycoplasma pneumoniae infection. This is crucial in clinical settings as it aids in the differential diagnosis of respiratory ailments, guiding appropriate treatment decisions. However, it's essential to interpret these results cautiously.

Elevated IgG levels alone cannot confirm an active infection, as these antibodies might remain in the system from a previous exposure. For a more accurate diagnosis, clinicians often consider the patient's clinical history, symptoms, and, if possible, conduct serial testing to observe changes in antibody levels over time. Elevated Mycoplasma Pneumoniae IgG in the absence of IgM might not warrant antibiotic treatment if the patient is asymptomatic.

Mycoplasma Pneumoniae Antibody (IgG) testing plays a pivotal role in the serological diagnosis of infections caused by the bacterium Mycoplasma pneumoniae, a common agent of atypical pneumonia and other respiratory tract infections.

This antibody is a specific type of immunoglobulin G (IgG), which the human immune system produces in response to an infection with this organism.

The presence and levels of Mycoplasma pneumoniae IgG antibodies in a patient's blood are measured to determine whether they have been exposed to the pathogen, either in the recent past or as a more distant infection. Typically, the body starts producing these antibodies 1-2 weeks after the initial infection, and their levels peak around 4-6 weeks post-infection.

Mycoplasma Pneumoniae Antibody (IgG) testing plays a pivotal role in the serological diagnosis of infections caused by the bacterium Mycoplasma pneumoniae, a common agent of atypical pneumonia and other respiratory tract infections.

This antibody is a specific type of immunoglobulin G (IgG), which the human immune system produces in response to an infection with this organism.

The presence and levels of Mycoplasma pneumoniae IgG antibodies in a patient's blood are measured to determine whether they have been exposed to the pathogen, either in the recent past or as a more distant infection. Typically, the body starts producing these antibodies 1-2 weeks after the initial infection, and their levels peak around 4-6 weeks post-infection.

The detection of IgG antibodies is crucial because it indicates a past or ongoing immune response against Mycoplasma pneumoniae.

However, it's important to note that the presence of IgG antibodies alone cannot definitively confirm an active infection, as they can persist in the bloodstream for months or even years after the initial exposure, indicating immunity from past infection.

Therefore, the interpretation of Mycoplasma pneumoniae IgG tests often involves considering the patient's clinical presentation, symptoms, and, if available, comparing antibody titers from acute and convalescent phases of the illness. This comparison can help to ascertain whether the detected antibodies are from a recent infection or a past exposure. In some cases, the testing for IgM antibodies, which are produced earlier in the infection, might be conducted alongside IgG testing for a more comprehensive understanding of the infection's timeline. Mycoplasma pneumoniae IgG antibody testing is a valuable tool in the epidemiological tracking and management of respiratory infections, particularly in outbreak settings or when diagnosing atypical pneumonia cases.

Mycoplasma Pneumoniae Antibody (IgG)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Mycoplasma Pneumoniae Antibody (IgG) — 10,000+ markers explained
One Mycoplasma Pneumoniae Antibody (IgG) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro